Christine Do Cao

6PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 19, 2025
Identification of metabolite biomarkers for pancreatic neuroendocrine tumours using a metabolomic approach.

Arnaud Jannin, Sophie Dabo-Niang, Christine Cao Do

|Nov 25, 2024
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET).

Thomas Walter, Thierry Lecomte, Julien Hadoux

|Oct 19, 2023
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.

Arnaud Jannin, Fabiola Giudici, Christelle de la Fouchardière

|Apr 19, 2023
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.

Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud

|Nov 15, 2022
Complete pathological response following chemotherapy and radiotherapy in two cases of advanced anaplastic thyroid carcinoma.

Benjamin Chevalier, Oriane Karleskind, Arnaud Jannin

|Nov 11, 2022
Impact of Lymph Node Dissection on Postoperative Complications of Total Thyroidectomy in Patients with Thyroid Carcinoma.

Gregory Baud, Arnaud Jannin, Camille Marciniak

Pageof 1

Frequent Collaborators

3 joint publications

Benjamin Chevalier

2 joint publications

Arnaud Jannin

2 joint publications

François Pattou

2 joint publications

Julien Hadoux